When it comes to heart disease, the go-to drug is, without a doubt, statins.
Now it could be the go-to for prostate cancer sufferers too.
According to a study published in JAMA Oncology, for men undergoing androgen deprivation therapy (ADT) for prostate cancer, the disease progresses less quickly if they're also using cholesterol-lowering statin drugs.
While previous research has sugges... ››› more
Androgen deprivation therapy (ADT) is a common treatment for prostate cancer. The treatment aims to reduce levels of male hormones (androgens) in the body to prevent them from reaching prostate cancer cells. There's now evidence that suggests this form of therapy could cause bone decay. Read on to discover the link between ADT and bone loss. It’s estimated that over 600,000 men are being treated... ››› more
Disclaimer: Copyright 2020, Fleet Street Publications. The information contained herein is obtained from sources believed to be reliable, but its accuracy cannot be guaranteed. No action or inaction should be taken based solely on the contents of this publication. We do research all our recommendations and articles thoroughly, but we disclaim all liability for any inaccuracies or omissions found in this publication. No part of this publication may be reproduced or transmitted in any form or by means of electronic or mechanical, including recording , photocopying, or via a computerised or electric storage or retrieval system without permission granted in writing from the publishers.